Ladenstein, R., Boubaker, A., Lambert, B., Castellani, M. R., Bar-Sever, Z., Oudoux, A., … Poetschger, U. (2014). SIGNIFICANT PROGNOSTIC RESULTS OF THE SIOPEN MIBG SCORING METHOD IN 2 COOPERATIVE INDEPENDENT HIGH RISK NEUROBLASTOMA TRIALS. PEDIATRIC BLOOD & CANCER, 61, S123–S123.

Ladenstein, R., A. Boubaker, B. Lambert, M. R. Castellani, Z. Bar-Sever, A. Oudoux, A. Kaminska, S. G. Kreissman, K. K. Matthay, and U. Poetschger. “SIGNIFICANT PROGNOSTIC RESULTS OF THE SIOPEN MIBG SCORING METHOD IN 2 COOPERATIVE INDEPENDENT HIGH RISK NEUROBLASTOMA TRIALS.” PEDIATRIC BLOOD & CANCER 61 (December 1, 2014): S123–S123.

Ladenstein R, Boubaker A, Lambert B, Castellani MR, Bar-Sever Z, Oudoux A, et al. SIGNIFICANT PROGNOSTIC RESULTS OF THE SIOPEN MIBG SCORING METHOD IN 2 COOPERATIVE INDEPENDENT HIGH RISK NEUROBLASTOMA TRIALS. PEDIATRIC BLOOD & CANCER. 2014 Dec 1;61:S123–S123.

Ladenstein, R., et al. “SIGNIFICANT PROGNOSTIC RESULTS OF THE SIOPEN MIBG SCORING METHOD IN 2 COOPERATIVE INDEPENDENT HIGH RISK NEUROBLASTOMA TRIALS.” PEDIATRIC BLOOD & CANCER, vol. 61, WILEY-BLACKWELL, Dec. 2014, pp. S123–S123.

Ladenstein R, Boubaker A, Lambert B, Castellani MR, Bar-Sever Z, Oudoux A, Kaminska A, Kreissman SG, Matthay KK, Poetschger U. SIGNIFICANT PROGNOSTIC RESULTS OF THE SIOPEN MIBG SCORING METHOD IN 2 COOPERATIVE INDEPENDENT HIGH RISK NEUROBLASTOMA TRIALS. PEDIATRIC BLOOD & CANCER. WILEY-BLACKWELL; 2014 Dec 1;61:S123–S123.